{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02d098-2021-08-17T16:39:41+01:00",
    "date": "2021-08-17T16:39:41+01:00",
    "ocid": "ocds-h6vhtk-02d098",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-02d098",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Prior Information Notice - Domestic Plasma Fractionation",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "33141510",
            "description": "Blood products"
        },
        "mainProcurementCategory": "goods",
        "description": "NHS England (NHSE), in conjunction with NHS Blood and Transplant (NHSBT) has published this Prior Information Notice (PIN) in relation to Domestic Plasma Fractionation. Please see full description for further details.",
        "lots": [
            {
                "id": "1",
                "description": "NHS England (NHSE), in conjunction with NHS Blood and Transplant (NHSBT) has published this Prior Information Notice (PIN) in relation to Domestic Plasma Fractionation.The PIN and associated Request for Information (RFI) seek to gather information and feedback from the plasma fractionation market, as recognised experts, to inform NHSE's strategy to contract for toll fractionation services (or similar services that would satisfy NHSE's requirements) using UK domestic plasma.Interested organisations can access the PIN and register their interest here https://health-family.force.com/s/Welcome Once registered, you will be invited to sign a tripartite non-disclosure agreement (NDA) before being provided access to the RFI, which we will be making available, subject to the NDA, no sooner than 6th August 2021We are requesting that the questionnaire included in the RFI is completed and returned by 1pm on the 31st August 2021. We will also be making time available for individual organisation discussions with NHSE and NHSBT between 6th and 17th September 2021 should this be considered helpful.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2021-08-04T00:00:00+01:00",
            "atypicalToolUrl": "http://health.atamis.co.uk"
        },
        "coveredBy": [
            "GPA"
        ],
        "amendments": [
            {
                "id": "1",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "NHS England (NHSE), in conjunction with NHS Blood and Transplant (NHSBT) has published this Prior Information Notice (PIN) in relation to Domestic Plasma Fractionation. Please see full description for further details."
                        },
                        "newValue": {
                            "text": "NHS England (NHSE), in conjunction with NHS Blood and Transplant (NHSBT) has published this Prior Information Notice (PIN) in relation to Domestic Plasma Fractionation. The PIN and associated Request for Information (RFI) seek to gather information and feedback from the plasma fractionation market, as recognised experts, to inform NHSE's strategy to contract for toll fractionation services (or similar services that would satisfy NHSE's requirements) using UK domestic plasma. Interested organisations can access the PIN and register their interest here https://health-family.force.com/s/Welcome Once registered, you will be invited to sign a tripartite non-disclosure agreement (NDA) before being provided access to the RFI, which we will be making available, subject to the NDA, no sooner than 6th August 2021 We are requesting that the questionnaire included in the RFI is completed and returned by 6 pm on the 5th September 2021. We will also be making time available for individual organisation discussions with NHSE and NHSBT between 6th and 17th September 2021 should this be considered helpful."
                        },
                        "where": {
                            "section": "II.2.4.1",
                            "label": "Description of procurement"
                        }
                    }
                ]
            }
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-3717",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House",
                "locality": "Leeds",
                "region": "UKE",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "liz.fleetwood1@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk//",
                "buyerProfile": "https://www.england.nhs.uk//",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-3717",
        "name": "NHS England"
    },
    "language": "en"
}